Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;23(4):e362-8.
doi: 10.3747/co.23.3051. Epub 2016 Aug 12.

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

Affiliations

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

M Giuliani et al. Curr Oncol. 2016 Aug.

Abstract

Purpose: In the present study, we determined the association of pretreatment circulating neutrophils, monocytes, and lymphocytes with clinical outcomes after lung stereotactic body radiotherapy (sbrt).

Methods: All patients with primary lung cancer and with a complete blood count within 3 months of lung sbrt from 2005 to 2012 were included. Overall survival (os) was calculated using the Kaplan-Meier method. Factors associated with os were investigated using univariable and multivariable Cox proportional hazards regression. Fine-Gray competing risk regression was performed to test the association of the neutrophil:lymphocyte (nlr) and monocyte:lymphocyte (mlr) ratios with two types of failure: disease-related failure and death, and death unrelated to disease.

Results: Of the 299 sbrt patients identified, 122 were eligible for analysis. The median and range of the nlr and mlr were 3.0 (0.3-22.0) and 0.4 (0.1-1.9) respectively. On multivariable analysis, sex (p = 0.02), T stage (p = 0.04), and nlr (p < 0.01) were associated with os. On multivariable analysis, T stage (p < 0.01) and mlr (p < 0.01) were associated with disease-related failure; mlr (p = 0.03), nlr (p < 0.01), and sbrt dose of 48 Gy in 4 fractions (p = 0.03) and 54 Gy or 60 Gy in 3 fractions (p = 0.02) were associated with disease-unrelated death. Median survival was 4.3 years in the nlr≤3 group (95% confidence interval: 3.5 to not reached) and 2.5 years in the nlr>3 group (95% confidence interval: 1.7 to 4.8; p < 0.01).

Conclusions: In lung sbrt patients, nlr and mlr are independently associated with os and disease-unrelated death. If validated, nlr and mlr could help to identify patients who would benefit most from sbrt.

Keywords: hemoglobin; lymphocytes; monocytes; neutrophils; outcomes; sabr; sbrt.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Pre-treatment distribution of neutrophils, lymphocytes, monocytes, platelets, hemoglobin, and white blood cells (WBC).
FIGURE 2
FIGURE 2
Kaplan–Meier curves for overall survival by neutrophil: lymphocyte (NL) ratio (NLR).
FIGURE 3
FIGURE 3
Cumulative incidence of disease-unrelated deaths and disease-related failure. NL = neutrophils:lymphocytes.

Similar articles

Cited by

References

    1. Dahele M, Brade A, Pearson S, Bezjak A. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer. CMAJ. 2009;180:1326–8. doi: 10.1503/cmaj.081291. - DOI - PMC - PubMed
    1. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radio-therapy versus lobectomy for operable stage i non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–7. doi: 10.1016/S1470-2045(15)70168-3. - DOI - PMC - PubMed
    1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070–6. doi: 10.1001/jama.2010.261. - DOI - PMC - PubMed
    1. Boily G, Filion E, Rakovich G, et al. on behalf of the Comité de l’évolution des pratiques en oncologie Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: cepo review and recommendations. J Thorac Oncol. 2015;10:872–82. doi: 10.1097/JTO.0000000000000524. - DOI - PubMed
    1. Huang SH, Waldron JN, Milosevic M, et al. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer. 2015;121:545–55. doi: 10.1002/cncr.29100. - DOI - PubMed

LinkOut - more resources